Target Audience

This accredited continuing education activity is designed for nurses, interested health care providers, and community members.

Educational Objectives

• Describe current treatment strategies for uterine fibroids to enhance interdisciplinary health care team knowledge.
• Explain the role, indications, and clinical effectiveness of minimally invasive treatment options for uterine fibroids in appropriate patient populations.
• Apply evidence-based education and quality improvement strategies to improve patient access to uterine fibroid care across clinical settings.

Speaker Bio

Maria T. O'Malley, MD
Assistant Professor
Department of Radiology
University of Nebraska Medical Center

Accreditation

In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Olson Center for Women's Health. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. The University of Nebraska Medical Center designates this activity for 1.0 ANCC contact hour. Nurses should only claim credit for the actual time spent participating in the activity.

Method of Participation

Release Date: 05/26/2026

Expiration Date: 5/26/2027

The estimated time to complete this enduring material is 60 minutes.

In order to receive continuing education credits, you must complete these steps prior to the activity expiration date.

• View the entire presentation
• Complete the post-test with a score of 2 out of 3 or better
• Complete the online evaluation
• Save and print your certificate. Retain for future documentation.

Any questions regarding credit, please contact Courtney Smith 402-559-6618 or courtneyl.smith@unmc.edu

Disclosure Information

As a jointly accredited provider, the University of Nebraska Medical Center (UNMC) ensures accuracy, balance, objectivity, independence, and scientific rigor in its educational activities and is committed to protecting learners from promotion, marketing, and commercial bias. Faculty (authors, presenters, speakers) are encouraged to provide a balanced view of therapeutic options by utilizing either generic names or other options available when utilizing trade names to ensure impartiality.
    All faculty, planners, and others in a position to control continuing education content participating in a UNMC accredited activity are required to disclose all financial relationships with ineligible companies. As defined by the Standards for Integrity and Independence in Accredited Continuing Education, ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The accredited provider is responsible for mitigating relevant financial relationships in accredited continuing education.  Disclosure of these commitments and/or relationships is included in these activity materials so that participants may formulate their own judgments in interpreting its content and evaluating its recommendations.
    This activity may include presentations in which faculty may discuss off-label and/or investigational use of pharmaceuticals or instruments not yet FDA-approved. Participants should note that the use of products outside currently FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for FDA-approved indications.
    All materials are included with the permission of the faculty. The opinions expressed are those of the faculty and are not to be construed as those of UNMC.

Disclosures

The accredited provider has mitigated and is disclosing identified relevant financial relationships for the following faculty, planners, and others in control of content prior to assuming their roles:

Faculty

The following faculty have nothing to disclose:
• Maria T. O'Malley, MD

Planning Committee

• Heidi Keeler, PhD, MSN/MBA, RN
• Lana Molczyk, MA
• Renee Paulin, DNP, MSN, RN, CWOCN
• Courtney Smith, MBA

Generative AI Disclosure Statement

In alignment with the University of Nebraska Medical Center (UNMC) Artificial Intelligence (AI) Policy, faculty and speakers must disclose if generative AI was used in creating content. They are responsible for verifying accuracy, ensuring transparency, and maintaining alignment with accreditation standards.

Financial Support

No commercial support was received for this activity.